Ilumya Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage Patient Counseling Information MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Tildrakizumab

Indications/Uses

Adults w/ moderate to severe plaque psoriasis who are candidates for systemic or phototherapy.

Click to view Ilumya detailed prescribing information

Dosage/Direction for Use

100 mg SC inj at wk 0, 4 & every 12 wk thereafter. Patient w/ high disease burden or >90 kg 200 mg may provide greater efficacy.

Click to view Ilumya detailed prescribing information

Overdosage

View Ilumya overdosage for action to be taken in the event of an overdose.

Contraindications

Hypersensitivity. Clinically important active infection eg, TB.

Click to view Ilumya detailed prescribing information

Special Precautions

Not to be inj into skin areas affected by plaque psoriasis or tender, bruised, red, hard, thick or scaly skin. Syringe must not be shaken. Discontinue immediately if serious hypersensitivity reaction occurs. Chronic infection or history of recurrent or recent serious infection. Evaluate for TB infection prior to initiation; consider anti-TB therapy prior to initiation in patients w/ past history of latent or active TB. Not to be used w/ live vaccines during & for at least 17 wk after treatment. May cause allergic reactions due to polysorbate 80. Women of childbearing potential should use effective contraception during & for at least 17 wk after treatment. Avoid use during pregnancy. Lactation.

Click to view Ilumya detailed prescribing information

Use In Pregnancy & Lactation

Click to view Ilumya detailed prescribing information

Adverse Reactions

URTI including nasopharyngitis. Headache; gastroenteritis, diarrhoea, nausea; back & inj site pain.

Click to view Ilumya detailed prescribing information

Drug Interactions

Not to be given concurrently w/ live vaccines.

Click to view Ilumya detailed prescribing information

Caution For Usage

For caution against possible variation of physical aspect of medicine... Click to view Ilumya detailed prescribing information

Storage

View Ilumya storage conditions for details to ensure optimal shelf-life.

Description

View Ilumya description for details of the chemical structure and excipients (inactive components).

Action

View Ilumya mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Immunosuppressants / Psoriasis, Seborrhea & Ichthyosis Preparations

ATC Classification

L04AC17 - tildrakizumab ; Belongs to the class of interleukin inhibitors. Used as immunosuppressants.

Regulatory Classification

Patient Counseling Information

View Ilumya patient counselling information

Presentation/Packing

Form

Ilumya soln for inj (pre-filled syringe) 100 mg/mL

Packing/Price

1's

Ilumya

tildrakizumab

Manufacturer:

Vetter Pharma

Distributor:

DKSH

Marketer:

Ranbaxy